Engineering Metal Nanoclusters for Targeted Therapeutics: From Targeting Strategies to Therapeutic Applications
Authors:
- 14 September 2021
- journal article
- review article
- Published by Wiley in Advanced Functional Materials
- Vol. 31 (51) , 2105662
Abstract
Metal nanoclusters (NCs) have recently attracted great interest in biomedical applications due to their ultrasmall size, good biocompatibility, and unique molecule‐like physical and chemical properties. Metal NCs can be rationally designed and integrated with various targeting moieties to achieve unique physicochemical properties and functions. For therapeutic applications, these multifunctional surface‐modified NCs can provide distinctive advantages over native metal NCs, such as improved therapeutic effects and reduced side effects. In this review, the design principles of targeting strategies for metal NCs and their composites, including passive and active targeting, and physical and chemical targeting are first discussed. The authors then focus on the recent achievements in the application of metal NCs in targeted therapeutics, including chemotherapy, phototherapy, and radiotherapy. Finally, the authors’ perspectives on the challenges and opportunities of developing metal NCs in targeted therapeutics, further paving their way for potential clinical applications are provided.Keywords
This publication has 240 references indexed in Scilit:
- Iron Oxide @ Polypyrrole Nanoparticles as a Multifunctional Drug Carrier for Remotely Controlled Cancer Therapy with Synergistic Antitumor EffectACS Nano, 2013
- Direct Observation of Nanoparticle–Cancer Cell Nucleus InteractionsACS Nano, 2012
- The transferrin receptor and the targeted delivery of therapeutic agents against cancerBiochimica et Biophysica Acta (BBA) - General Subjects, 2012
- Atomically precise gold nanocrystal molecules with surface plasmon resonanceProceedings of the National Academy of Sciences, 2012
- Selective Targeting of Antibody Conjugated Multifunctional Nanoclusters (Nanoroses) to Epidermal Growth Factor Receptors in Cancer CellsLangmuir, 2011
- A Nanoparticle Size Series for In Vivo Fluorescence ImagingAngewandte Chemie International Edition, 2010
- Dynamic Visualization of RGD‐Quantum Dot Binding to Tumor Neovasculature and Extravasation in Multiple Living Mouse Models Using Intravital MicroscopySmall, 2010
- The Nucleolin Targeting Aptamer AS1411 Destabilizes Bcl-2 Messenger RNA in Human Breast Cancer CellsCancer Research, 2008
- The resurgence of platinum-based cancer chemotherapyNature Reviews Cancer, 2007
- Highly Fluorescent Noble-Metal Quantum DotsAnnual Review of Physical Chemistry, 2007